Stay updated on Oncolytics Biotech Press Releases
Sign up to get notified when there's something new on the Oncolytics Biotech Press Releases page.

Latest updates to the Oncolytics Biotech Press Releases page
- Check2 days agoChange DetectedThe investor overview now lists a publication on pelareorep’s immune effects in liver cancer and accelerated enrollment in a colorectal cancer study, replacing earlier FDA-pathway and Fast Track announcements. The displayed stock quote has also updated.SummaryDifference3%

- Check9 days agoChange DetectedThe Investor Overview page now shows updated NASD:ONCY stock data: price $0.68, daily change $0.004, and a 0.59% move. These figures replace the previous values of $0.77, $0, and 0.00%.SummaryDifference0.9%

- Check16 days agoChange DetectedThe Stock Information block on the Investor Overview now displays a price of $0.77 with a change of $0 and 0.00%. The previous figures shown were $0.75, -$0.026, and -3.37%.SummaryDifference0.9%

- Check23 days agoChange DetectedUpdated stock pricing data and a new press release headline about pelareorep in colorectal cancer have been added to the Investor Overview, while an earlier price entry and an older FDA milestone press release have been removed.SummaryDifference3%

- Check30 days agoChange DetectedThe stock information updated to show a current price of $0.84 with a change of -$0.014 and -1.63%, replacing the previous values of $0.86, $0.007, and 0.82%.SummaryDifference0.9%

- Check37 days agoChange DetectedOn the Investor Overview page, the NASD:ONCY stock quote values were updated: the price moved from 0.84 to 0.86, the intraday change from 0.041 to 0.007, and the daily percentage change from 5.11% to 0.82%.SummaryDifference1%

Stay in the know with updates to Oncolytics Biotech Press Releases
Enter your email address, and we'll notify you when there's something new on the Oncolytics Biotech Press Releases page.